Enrique Miranda
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 8
- HER2/EGFR in Cancer Research 6
- CAR-T cell therapy research 2
-
- Monoclonal and Polyclonal Antibodies Research 7
- Co-authors
- Kerry Ann Chester (7 shared papers)Mark E. B. Smith (3 shared papers)Vijay Chudasama (3 shared papers)Antoine Maruani (2 shared papers)Stephen Caddick (2 shared papers)James R. Baker (3 shared papers)Gunnel Halldén (3 shared papers)Emilio R. Rojas (1 shared paper)
- Journals
- Bioconjugate Chemistry (2 papers)PLoS ONE (2 papers)Immunity (1 paper)Biotechnology and Bioengineering (1 paper)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)
- Partner nations
- United KingdomMexicoUnited States
In The Last Decade
Enrique Miranda
14 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 74
- Oncology 532
- Radiology, Nuclear Medicine and Imaging 367
- Immunology 288
- Biotechnology 54
- Molecular Biology 419
Countries citing papers authored by Enrique Miranda
This map shows the geographic impact of Enrique Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique Miranda more than expected).
Fields of papers citing papers by Enrique Miranda
This network shows the impact of papers produced by Enrique Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique Miranda. The network helps show where Enrique Miranda may publish in the future.
Co-authors
The 25 scholars most cited alongside Enrique Miranda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 369 | |
| 2 | 2015 | 217 | |
| 3 | 1997 | 80 | |
| 4 | 2014 | 75 | |
| 5 | 2013 | 64 | |
| 6 | 2009 | 61 | |
| 7 | 2014 | 53 | |
| 8 | 2018 | 47 | |
| 9 | 2010 | 25 | |
| 10 | 2015 | 15 | |
| 11 | 2005 | 14 | |
| 12 | 2013 | 13 | |
| 13 | 2012 | 12 | |
| 14 | 2011 | 7 |
About Enrique Miranda
Enrique Miranda is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Genetics, Immunology and Molecular Biology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers), Virus-based gene therapy research (3 papers), CAR-T cell therapy research (2 papers), Protein purification and stability (2 papers), Immunotherapy and Immune Responses (2 papers), Nanofabrication and Lithography Techniques (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Oncology (532 citations), Radiology, Nuclear Medicine and Imaging (367 citations), Immunology (288 citations), Biotechnology (54 citations) and Molecular Biology (419 citations). Enrique Miranda has collaborated with scholars based in United Kingdom, Mexico and United States. Frequent co-authors include Kerry Ann Chester, Mark E. B. Smith, Vijay Chudasama, Antoine Maruani, Stephen Caddick, James R. Baker, Gunnel Halldén, Emilio R. Rojas, Alejandro M. García-Carrancá and Patricia Ostrosky‐Wegman. Their work appears in journals such as Bioconjugate Chemistry, PLoS ONE, Immunity, Biotechnology and Bioengineering and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.